11:40 Diagnosing the undiagnosed and engaging the disengaged. Dr Andy Ustianowski Jon Derricott 267 views - 7 years ago
12:33 Charles Gore: Reflections on 18 years at the Hepatitis C Trust and the future for hepatitis C Jon Derricott 253 views - 7 years ago
15:49 LJWG pharmacy testing & treatment overview. Dr Suman Verma Jon Derricott 248 views - 7 years ago
10:16 The LJWG project on the importance of data processes in pathways. Dr Katherine Morely, Jon Derricott 41 views - 7 years ago
11:39 Economic evaluations of case finding for PWID who have hepatitis C. Professor Peter Vickerman Jon Derricott 270 views - 7 years ago
10:27 The changing landscape & the future of hepatitis C treatment. Janet Catt/Chris Laker Jon Derricott 112 views - 7 years ago
10:24 Addressing the health inequalities issue of hepatitis C in London.Dr Yvonne Doyle Jon Derricott 334 views - 7 years ago
5:40 LJWG Conference 2018. 7 years to HCV elimination: The road to 2025. Stuart Smith Jon Derricott 108 views - 7 years ago
4:16 There's a footprint to leave: Hepatitis C elimination in London Jon Derricott 219 views - 7 years ago
11:44 Tobacco harm reduction roadshow - Leicester, Liverpool & Glasgow Jon Derricott 109 views - 8 years ago
14:20 Users of anabolic steroids and associated drugs. A sentinel population Jon Derricott 851 views - 9 years ago
16:49 Supervised injecting in Scotland? A travel fellowship experience. Jon Derricott 266 views - 9 years ago
16:54 Mat Southwell - drug user organising and the work of EURONPUD Jon Derricott 188 views - 9 years ago
18:58 Problematising Hepatitis C Treatment Priorities in England Jon Derricott 201 views - 9 years ago
13:36 The Janus face of drug prohibition: which way are we heading? Jon Derricott 203 views - 9 years ago
19:17 GFN2016: E-cigarettes health potential: current evidence and future areas of exploration Jon Derricott 1.9K views - 9 years ago
8:11 GFN2016: 'Not Blowing Smoke' - the fight against misleading messages Jon Derricott 477 views - 9 years ago
7:11 GFN2016: Disharmony in the Implementation of the European TPD Jon Derricott 545 views - 9 years ago
14:05 GFN2016: Population impacts of snus - tobacco initiation & cessation Jon Derricott 1.1K views - 9 years ago
16:33 GFN2016: Lessons for vapers from drugs harm reduction and drug policy reform Jon Derricott 729 views - 9 years ago
21:29 GFN2016: What would good regulation of e-cigarettes look like? Jon Derricott 455 views - 9 years ago
24:44 GFN2016: Unacountable and non-transparent: is the FCTC a threat to public health? Jon Derricott 281 views - 9 years ago
12:08 GFN2016: Population impact of e-cigarettes: recent evidence from the UK Jon Derricott 431 views - 9 years ago
11:58 GFN2016: Asking the right questions about smoking and alternative nicotine delivery systems Jon Derricott 715 views - 9 years ago
16:38 GFN2016: Perceptual and experiential factors in switching to e-cigarettes Jon Derricott 202 views - 9 years ago
17:31 GFN2016: E-cigarettes: Gateway or Roadblock to Cigarette Smoking? Jon Derricott 183 views - 9 years ago
17:38 GFN2016: Tobacco Heating System (THS) 2.2 cardiovascular disease risk assessment Jon Derricott 2.7K views - 9 years ago
15:55 GFN2016: Compensatory puffing behaviours in e-cigarette users Jon Derricott 340 views - 9 years ago
12:43 GFN2016: The power of non-nicotine factors in the habitual use of nicotine products Jon Derricott 860 views - 9 years ago